Trial intelligence / Profile preview

Physiologic Monitoring of Antidepressant Treatment Response

NCT00792168Phase 4Completed

Sponsor
University of California, Los Angeles
Start
Nov 1996
Primary completion
Nov 1996
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of venlafaxine in major depressive disorder (MDD), sponsored by University of California, Los Angeles. Started Nov 1996; status: completed.

02

Drugs

venlafaxine
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00792168.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00792168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call